Impact of Pharmacologic Interventions—Treating Endothelial Dysfunction and Group 2 Pulmonary Hypertension

This publication has 47 references indexed in Scilit:

• Pulmonary Hypertension in Heart Failure Preserved Ejection Fraction
  Circulation: Heart Failure, 2014
• Pulmonary Hypertension Due to Left Heart Disease
  Circulation, 2012
• Benefit of prostaglandin infusion in severe heart failure
  International Journal of Cardiology, 2011
• Pulmonary hypertension with left-sided heart disease
  Nature Reviews Cardiology, 2010
• Caveat Medicus! Pulmonary Hypertension in the Elderly: A Word of Caution
  European Journal of Heart Failure, 2009
• Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
  European Heart Journal, 2009
• Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population
  Circulation, 2009
• Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
  JACC, 2009
• Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
  JACC, 2001
• Safety and efficacy of epoprostenol in patients with severe congestive heart failure
  The American Journal of Cardiology, 1995